Story perspectives

New Gut Metabolite Linked to Early Atherosclerosis Risk

7/17/2025

45 8

Summary

Story summary

Spanish researchers at the National Center for Cardiovascular Research (CNIC) have unveiled a startling connection between imidazole propionate (ImP), a gut microbiota metabolite, and early-stage atherosclerosis in healthy individuals. By triggering inflammation and plaque buildup in arteries, this discovery paves the way for innovative diagnostic tools and treatments, promising to revolutionize the early detection and management of cardiovascular disease.

1 of 1

Story summary

Spanish researchers at the National Center for Cardiovascular Research (CNIC) have unveiled a startling connection between imidazole propionate (ImP), a gut microbiota metabolite, and early-stage atherosclerosis in healthy individuals. By triggering inflammation and plaque buildup in arteries, this discovery paves the way for innovative diagnostic tools and treatments, promising to revolutionize the early detection and management of cardiovascular disease.